Role of bioinformatics in the development of new antibacterial therapy

Expert Review of Anti-Infective Therapy

Volumn 6, Issue 1, 2008, Pages 51-65

  Bansal, Arvind K ^a  

^a KENT STATE UNIVERSITY   (United States)

Author keywords

Antibiotic; Bioinformatics; Drug resistance; Genomics; Pathogenicity; Vaccine

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; EXOTOXIN; MICRORNA; VACCINE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; BACTERIAL METABOLISM; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BIOINFORMATICS; CELL DEATH; CELL TRANSPORT; COMPARATIVE GENOMIC HYBRIDIZATION; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG RESEARCH; FACTUAL DATABASE; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE REARRANGEMENT; GENE SEQUENCE; HORIZONTAL GENE TRANSFER; HOST PATHOGEN INTERACTION; HUMAN; MICROARRAY ANALYSIS; MOLECULAR DOCKING; MOLECULAR MODEL; NONHUMAN; REVIEW; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; VACCINE PRODUCTION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COMPUTATIONAL BIOLOGY; DRUG RESISTANCE, BACTERIAL; HUMANS; TECHNOLOGY, PHARMACEUTICAL;

EID: 40749091964     PISSN: 14787210     EISSN: 17448336     Source Type: Journal    
DOI: 10.1586/14787210.6.1.51     Document Type: Review

References (121)

1. Martinez J, Baquero F. Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistance. Clin. Microbiol. Rev. 15(4), 647-679 (2002).
2. Therrien C, Levesque RC. Molecular basis of antibiotic resistance and β-lactamase inhibition by mechanism-based inactivators: perspectives and future directions. FEMS Microbiol. Rev. 24, 251-262 (2000).
3. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science 264(5157), 375-382 (1994).
4. Finlay BB, Falkow S. Common themes in microbial pathogenicity revisited. Microbiol. Mol. Biol. Rev. 61(2), 136-169 (1997).
5. Armstrong D. History of opportunistic infection in the immunocompromised host. Clin. Inf. Dis. 17 (Suppl. 2) S318-S321 (1993).
6. Casadevall A, Pirofski LA. Host-pathogen interactions: basic concepts of microbial commensalism, colonization, infection, and disease. Infect. Immun. 68(12), 6511-6518 (2000).
7. Swartz MN. Hospital-acquired infections: diseases with increasingly limited therapies, Proc. Natl Acad. Sci. USA 91, 2420-2427 (1994).
8. Kupperwasser LI, Skurray RA, Brown MH et al. Plasmid mediated resistance to thrombin-induced platelet microbicidal protein in staphylococci: role of qacA locus. Antimicrob. Agents Chemother. 43(10), 2395-2399 (1999).
9. Mounier JA, Ryter M, Ciquis-Rondon M, Sansonetti PJ. Intracellular and cell-to-cell spread of Listeria monocytogens involve interaction with F-actin enterocytelike cell line Caco-2. Infect. Immun. 58, 1048-1058 (1990).
10. Ochman H, Mora NA. Genes lost and genes found: evolution of bacterial pathogenesis and symbiosis. Science 292, 1096-1098 (2001).
11. Chopra I, Hodgson J, Metcalf B, Poste G, The search for antimicrobial agents effective against bacteria resistant to multiple antibiotics. Antimicrob. Agents Chemother. 41, 497-503 (1997).
12. Leclerc JE, Li B, Payne WL, Cédula TA. High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274, 1208-1211 (1996).
13. Tenover FC, Hughes JM. The challenges of emerging infectious diseases: development and spread of multiple-resistant bacterial pathogens. Science 275, 300 (1996).
14. Barocchi MA, Censini S, Rappuoli R. Vaccines in the era of genomics: the pneumococcal challenge. Vaccine 25, 2963-2973 (2007).
15. DeGroot AS, Bosma A, Chinai N et al. From genome to vaccine: in silico predictions, ex vivo verification. Vaccine 19(31), 4385-4395 (2001).
16. Gerdes SY, Scholle MD, D'Souza M, Bernal A et al. From genetic footprinting to antimicrobial drug targets: examples in cofactor biosynthetic pathways. J. Bacteriol. 184(16), 4555-4572 (2002).
17. Girard MP, Prezioski M, Aguado M et al. A review of vaccine research and development: meningococcal disease. Vaccine 24, 4692-4700 (2006).
18. Liu J, Dehbi M, Moeck G et al. Antimicrobial drug discovery through bacteriophage genomics. Nat. Biotechnol. 22(2), 185-191 (2004).
19. Halperin I, Ma B, Wolfson H, Nussinov R. Principles of docking: An overview of search algorithms and a guide to scoring functions. Proteins 47(4), 409-43 (2002).
20. Baker D, Sali A. Protein structure prediction and structural genomics. Science 294, 93-96 (2001).
21. Franklin TJ, Snow GA. Biochemistry and Molecular Biology of Antimicrobial Drug Action (5th Editton). Kluwer Academic, USA (1998).
22. Cotter PA, Miller JF. Triggering bacterial virulence. Science 273, 1183-1184 (1996).
23. Hacker J, Blum-Oehler G, Muhldorfer I, Tschape H. Pathogenicity islands of virulent bacteria: structure, function, and impact on microbial evolution. Mol. Microbiol. 23, 1089-1097(1997).
24. Wang W, Kollman PA. Computational study of protein specificity, the molecular basis of HIV-1 protease drug resistance. Proc. Natl Acad. Sci. USA 98, 14937-14942 (2001).
25. Zhou J, Thompson DK, Xu, Y, Tiedje JM, Microbial Functional Genomics. Wiley, NJ, USA (2004).
26. Hagman KE, Shafer WE. Transcriptional control of the mtr efflux system of Neisseria gonorrhoeae. J. Bacteriol. 177(14), 4162-4165 (1995).
27. Nikaido H. Multidrug efflux pumps of Gram negative bacteria. J. Bacteriol. 178(20), 5853-5859 (1996).
28. Salyers AA et al. Conjugative transposons: an unusual and diverse set of gene transfer elements. Microbiol. Rev. 59, 579 (1995).
29. Walsh C. Molecular mechanisms that confer antibacterial drug resistance. Nature 406, 775-781 (2000).
30. Wilson JM, Schurr MJ, Leblanc CL et al. Mechanisms of bacterial pathogenicity. Post Grad. Med. J. 78, 216-224 (2002).
31. Maurelli AT, Fernandez RE, Bloch CA et al. Black holes and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp and enteroinvasive Escherichia coli. Proc. Natl Acad. Sci. USA 95, 3943-3948 (1998).
32. Watanbe H, Nakamura A. Large plasmids associated with virulence in Shigella species have a common function necessary for epithelial cell penetration. Infect. Immun. 48(1), 260-262 (1985).
33. Poole K, Krebes K, McNally C, Neshat S. Multiple antibiotic resistance in Pseudomonas aeruginosa: evidence for involvement of an efflux operon. J. Bacteriol. 175(22), 7363-7372 (1993).
34. Tenaillon O, Taddei F, Radman M, Matic I. Second order selection in bacterial evolution: selection acting on mutation and recombination rates in the course of adaptation. Res. Microbiol. 152, 11-16 (2001).
35. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 284, 1318-1322 (1999).
36. Jeffrey CJ. Moonlighting proteins: old proteins learning new tricks. Trend Genet. 19, 415-417 (2003).
37. Portnoy DA, Wolf-Watz H, Bolin I et al. Characterization of common virulence plasmids in Yersinia species and their role in the expression of outer membrane proteins. Infect. Immun. 43(1), 108-114 (1984).
38. Ozeri R, Khazanov N, Perlman N, Shokhen M, Albeck A. Enzyme isoselective inhibitors: a tool for binding trend analysis. ChemMedChem. 1, 631-638 (2006).
39. Shokhen M, Khazanov N, Albeck A. Enzyme isoselective inhibitors: application to drug design. ChemMedChem 1, 639-643 (2006).
40. Shokhen M, Khazanov N, Albeck A. Enzyme inhibition trend analysis - a new method for drug design. FEBS J. 272(Suppl. 1), B1-007 (2006).
41. Gunn JS, Miller SI. PhoP-PhoQ activates transcription of pmrAB encoding a two-component regulatory system involved in Salmonella typhirium antimicrobial peptide resistance. J. Bacteriol. 178(23), 6857-6864 (1996).
42. Van Velkinburgh JC, Gunn JS. PhoP-PhoQ regulated loci are required for enhanced bile resistance in Salmonella spp. Infect. Immun. 67(4), 1614-1622 (1999).
43. Bansal AK. An automated comparative analysis of seventeen complete microbial genomes. Bioinformatics 15(11), 900-908 (1999).
44. Bansal AK. Integrating co-regulated gene-groups and pair-wise genome comparisons to automate reconstruction of microbial pathways. Proceedings of IEEE International Symposium on Bioinformatics and Biomedical Engineering. Washington DC, USA 209-216 (2001).
45. Bono H, Ogata H, Goto S, Kanehisa M. Reconstruction of amino acid biosynthesis pathways from the complete genome sequence. Genome Res 8(3), 203-210 (1998).
46. Goto S, Nishioka T, Kanehisa M. LIGAND: chemical database for enzyme reactions. Bioinformatics 14 (7), 591-599 (1998).
47. Kelley BP, Sharan R, Karp RM et al. Conserved pathways within bacteria and yeast as revealed by global protein network alignment. Proc. Natl Acad. Sci. USA 100(20), 11394-11399 (2003).
48. Courvalin P. Transfer of antibiotic resistant genes between Gram-positive and Gram-negative bacteria. Antimicrob. Agents Chemother. 38, 1447 (1994).
49. Ochman H, Lawrence JG, Groisman EA. Lateral gene-transfer and the nature of bacterial innovation. Nature 405, 299-304 (2000).
50. Salyers AA, CF Amabile-Cuevas. Why are antibiotic resistance genes so resistant to elimination? Antimicrob. Agents Chemother. 41, 2321-2325 (1997).
51. Dean PM, Lloyd DG, Todorov NP. De novo drug design: integration of structure-based and ligand-based methods. Curr. Opin. Drug Disc. Dev. 7, 347-353 (2006).
52. Benson DA, Karsch-Mizrachi I, Lipman DJ et al. GenBank. Nucleic Acids Res. 33, D34-D38 (2000).
53. Berman HM, Westbrook J, Feng Z et al. The Protein Data Bank. Nucleic Acids Res. 28(1), 235-242 (2000).
54. Mulder NJ, Apweiler R, Attwood TK et al. Interpro: an integrated documentation resource for protein families, domains and functional sites. Bioinformatics 16, 1145-50 (2001).
55. Bateman A, Coin L, Durbin R et al. The Pfam protein families database. Nucleic Acids Res. 32, D138-D141 (2004).
56. Chen X, Ji ZL, Chen YZ. TTD: Therapeutic target database. Nucleic Acids Res. 30(1), 412-415 (2002).
57. Kanehisa M, Goto S, Hattori M et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 34, D354-357 (2006).
58. Ogata H, Goto S, Fujibuchi W, Kanehisa M. Computation with the KEGG pathway database. Biosystems 47, 119-128 (1996).
59. Puvanendrampillai D, Mitchell JBO. Protein Ligand Database (PLD): additional understandhig of the nature and specificity of protein-ligand complexes. Bioinformatics 19(14), 1856-1857 (2003).
60. Salgado H, Gama-Castro S, Martínez-Antonio, A et al. RegulonDB (version 4.0): transcriptional regulation, operon organization and growth conditions in Escherichia coli K - 12. Nucleic Acids Res. 32, 303-306 (2004).
61. Tatusov RL, Natale DA, Garkavtsev IV et al. The COG Database: new developments in phylogenetic classifications from complete genome. Nucleic Acids Res. 29(1), 22-28 (2001).
62. McGuire AM, Hughes JD, Church GM. Conservation of DNA regulatory motifs and discovery of new motifs in microbial genomes. Genome Res. 10(6), 744-757 (2000).
63. Mount DW. Bioinformatics: Sequence and Genome Analysis. Cold Spring Harbor Laboratory Press, NY, USA (2000).
64. Waterman MS. Introduction to Computational Biology, Maps, Sequence, and Genomes. Chapman & Hall, London, UK (1995).
65. Delcher AL, Harmon D, Kasif S, White O, Salzberg SL. Improved microbial gene identification with GLIMMER. Nucleic Acids Res. 27(23), 4636-4641 (1999).
66. Azad RK, Borodovsky M. Probabilistic methods of identifying genes in prokaryotic genomes: connections to the HMM theory. Brief Bioinformatics 5 (2), 118-130 (2004).
67. Lukashin AV, Borodovsky M. GeneMark.hmm: new solutions for gene finding. Nucleic Acids Res. 26 (4), 1107-1115 (1998).
68. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic alignment search tools. J. Mol. Biol. 215, 403-410 (1990).
69. Altschul SF, Madden TL, Schaffer AA et al. Gapped BLAST and PSI-BLAST. a new generation of protein database search programs. Nucleic Acids Res. 15(17), 3389-3402 (1997).
70. Suzek BE, Ermolaeva MD, Schreiber M, Salzberg SL. A probabilistic method for identifying start codons in bacterial genomes. Bioinformatics 17(12), 1123-1130 (2001).
71. Henikoff S, Henikoff JG, Alford WJ, Pietrokovski S. Automated construction and graphical presentation of protein blocks from unaligned sequences Gene 163(2), GC17-GC26 (1995).
72. Chenna R, Sugawaral H, Koike Lopez TR, Gibson TJ, Higgins DJ, Thompson JD. Multiple sequence alignment with the clustal series of programs. Nucleic Acids Res. 31(13), 3497-3500 (2003).
73. Gomez A, Domedel N, Cedano J, Penol J, Querol E. Do current sequence analysis algorithms disclose multifunctional (moonlighting) proteins? Bioinformatics 19, 895-896 (2003).
74. Catherine B, Emmanuel C, Sébastien C, Yoann B, Sandrine D, Daniel K. The ProDom database of protein domain families: more emphasis on 3D. Nucleic Acids Res. 33, D212-D215 (2000).
75. Sonnhammer EL, Eddy SR, Birney E, Batman A, Durbin R. Pfam: multiple sequence alignments and HMM-profiles of protein domains. Nucleic Acids Res. 26, 320-322 (1998).
76. Finn RD, Mistry J, Schuster-Böckle B et al. Pfam: clans, web tools and services. Nucleic Acids Res. 34, D247-D251 (2006).
77. Tatusov RL, Mushegian M, Bork P et al. Metabolism and evolution of Haemophilius influenzae deduced from a whole-genome comparison with Escherichia coli. Curr Biol. 6, 279-291 (1996).
78. Bansal AK, Myer TE. Evolutionary analysis by whole genome comparisons. J. Bacteriol. 184(8), 2260-2272 (2002).
79. Robinson WH, Fontoura P, Lee BJ et al. Protein micro arrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis. Nat. Biotechnol. 21(9), 1033-1039 (2003).
80. Zagursky RJ, Olmsted SB, Russell DP, Wooters JL. Bioinformatics: how it is being used to identify bacterial vaccine candidates. Vaccines 2(3), 417-436 (2003).
81. Durand D, Sankoff D. Tests for gene clustering. J. Comput. Biol. 10(3/4), 453-482 (2003).
82. Bairoch A, Apweiler R, Wu CH, et al. The Universal Protein Resource (UniProt). Nucleic Acids Res. 33, D154-D159 (2005).
83. Schilling CH, Covert MW, Famili I, Church GM, Edwards JS, Palsson BØ. Genome-scale metabolic model of Helicobacter pylori 26695. J. Bacteriol. 184(6), 4582-4593(2002).
84. Schuster S, Dandekar T, Fell DA. Detection of elementary flux modes in biochemical networks: a promising tool for pathway analysis and metabolic engineering. Trends Biotechnol. 17(2), 53-60 (1999).
85. Papin JA, Price ND, Palsson BØ. Extreme pathway lengths and reaction participation in genome-scale metabolic networks. Genome Res. 12(12), 1889-1900 (2002).
86. Luscombe NM, Laskowski RA, Thornton JM. Amino acid base interactions: a three dimensional analysis of protein-DNA interactions at an atomic level. Nucleic Acid Res. 29(13), 2860-2874 (2001).
87. Guthke R, Ulrich M, Hoffman M et al. Dynamic network reconstruction from gene expression data applied to immune response during bacterial infection. Bioinformatics. 21(8), 1626-1634 (2005).
88. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA micro array. Science 270, 467-470. (1995).
89. Stekel DJ, Sarti D, Trevino V. Analysis of host response to bacterial infection using error model based gene expression micro array experiments. Nucelic Acids Res. 33(6), 1-13 (2005).
90. Waddell PJ, Kishino H. Cluster inference methods and graphical models evaluated on NCI60 micro array gene expression data. Genome Inform. 11, 129-140 (2000).
91. Eskin E, Pevzner PA. Finding composite regulatory patterns in DNA sequences. Bioinformatics 18(1), 354-363 (2002).
92. Mironov AA, Koonin EV, Roytberg MA, Gelfand MS. Computer analysis of transcription regulatory patterns in completely sequenced bacterial genomes. Nucleic Acids Res. 27, 2981-2989 (1999).
93. Bar-Joseph Z, Gerber GK, Lee TI, et al. Computational discovery of gene modules and regulatory networks. Nat. Biotechnol: 21(11), 1337-1342 (2003).
94. Butte A, Kohan I. Mutual information relevance networks: functional genomics clustering using pair-wise entropy measurements. Pac. Symp. Biocomput. 418-429 (2000).
95. Girardin SE, Boneca IG, Viala J et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 2003. 278, 8869-8872 (2003).
96. Mwangi MM, Siggia ED. Genome wide identification of regulatory motifs in Bacillus subtilis BMC. Bioinformatics 4(1), 18-20 (2003).
97. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
98. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Genetics 5, 522-532 (2004).
99. Carthew RW. Gene regulation by microRNAs. Curr. Opin. Genet. Dev. 16(2), 203-208 (2006):
100. Navarro L, Dunoyer P, Jay F et al. A plant miRNA contributes to antibacterial resistance by repressing auxin signaling. Science 312(5772), 436-439 (2006).
101. del Solar G, Espinosa M. Plasmid copy number control: an ever-growing story. Mol. Microbiol. 37, 492-500(2001).
102. Mlynarczyk SK, Panning B. X inactivation: Tsix and Xist as yin and yang. Curr. Biol. 10, R899-R903(2000).
103. Rajewsky N, Socci ND. Computational Identification of microRNA targets. Dev. Biol. 267, 529-535 (2003).
104. Rhoades MW, Reinhart BJ, Lim LP, Burge CB, Bartel B, Bartel DP. Prediction of plant microRNA targets. Cell 110, 513-520 (2002).
105. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ. miRBase: microRNA sequences, targets and gene nomenclature Nucleic Acid Res. 34, D140-D144(2006).
106. Szymanski M, Erdmann VA, Barciszewski J. Noncoding regulatory RNA database. Nucleic Acids Res. 31, 429-431 (2003).
107. Rost B, Sander C. Prediction of protein secondary structure at better than 70 percent accuracy J. Mol. Biol. 232, 584-599 (1995).
108. Whisstock JC, Lesk AM. Prediction of protein function from protein sequence and structure. Q. Rev. Biophys. 36(3), 307-340 (2003).
109. DeJonge MI, Brosch R, Brodin P. Tuberculosis: from genome to vaccine. Expert Rev. Vaccines. 4(4), 541-551 (2005).
110. Pizza M. Identification of vaccine candidates against Serogroup B meningococcus by whole genome sequencing, Science 287, 1816-1820 (2000).
111. Prokhorva TA, Nielsen PN, Petersen J et al. Novel surface polypeptides of Campylobacter jejuni as traveler's diarrhea vaccine candidates discovered by proteomics. Vaccine 24, 6446-6455 (2006).
112. Shaila MS, Nayak R, Prakash SS et al. Comparative in silico analysis of two vaccine candidates for group A streptococcus predicts that they both may have similar profiles. Vaccine 25, 3567-3573 (2007).
113. Skjøt RLV, Agger EM, Andersen P. Antigen discovery and tuberculosis vaccine development in the post-genomic era. Scand. J. Infect. Dis. 33(9), 643-647 (2001).
114. Giuliani MM, Adu-Bobie J. Comanducci J et al. A universal vaccine for serogroup B. meningococcus. Proc. Natl Acad. Sci. USA 103(29), 10834-10839 (2006).
115. Montgomery DL. Tuberculosis vaccine design: influenee of the completed genome sequence. Briefing in Bioinformatics 1(3), 289-296 (2000).
116. Garcia-del PF, Pucciarelli, MG, Casadesus J. DNA adenine methylase mutants of Saimonella typhimurium show defects in protein secretion, cell invasion, and M cell cytotoxicity. Proc. Natl. Acad. Sci. USA 96, 11578-11583 (1999).
117. Honma Y, Fernández RE, Maurelli AT. A DNA adenine methylase mutant of Shigella flexneri shows no significant attenuation of virulence. Microbiology 150, 1973-1978 (2004).
118. Moir DT, Shaw KJ, Hare RS, Vovis GF. Genomics and antimicrobial drug discovery. Antimicrob. Agents Chemother. 43(3), 439-446 (1999).
119. Rosamond J, Allsop A. Harnessing the power of the genome in the search for new antibiotics. Science 287, 1973-1976 (2000).
120. Tucker BJ, Breaker RR. Riboswitches as versatile gene control elements. Curr. Opin. Struct. Biol. 15, 342-348 (2005).
121. Marck C, Grosjean H. tRNAomics: Analysis of tRNA genes from 5-genomes of eukarya, archaea, and bacteria reveals anti-codon-sparing strategies and domain-specific features. RNA 8, 1189-1232 (2002).